UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in NTLA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,640,336
+$1,489,510 QoQ
Shares Held
283,958
+18.7% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. NTLA ranks #80 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,640,336 | 283,958 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,150,826 | 239,247 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,166,936 | 241,282 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,983,133 | 637,861 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,709,327 | 521,706 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $5,633,933 | 483,185 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,453,242 | 460,012 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,465,471 | 512,309 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,443,839 | 379,638 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,172,041 | 432,012 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $12,881,509 | 407,385 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,075,603 | 418,725 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,605,877 | 418,725 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $13,720,278 | 393,244 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,556,074 | 403,075 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,223,918 | 371,405 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $23,211,084 | 319,404 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $34,122,759 | 288,589 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $38,811,736 | 289,316 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $44,281,085 | 273,492 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $18,554,231 | 231,191 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $15,286,344 | 280,999 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $1,293,729 | 65,077 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,259,958 | 59,941 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $596,737 | 48,793 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||